Integration of IMRT and brachytherapy

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

Combinations of external beam radiotherapy and interstitial or intracavitary brachytherapy have been effectively used in variety of clinically settings since the introduction of megavoltage beam therapy in the 1950s. Generally, brachytherapy is used to administer high doses to unresected or residual primary tumor while external beamradiotherapy is used to delivermore modest doses to larger volumes of adjacent tissue or regional lymph nodes at high risk for microscopic invasion. Conventionally, relatively simple external beam field arrangements are used to administer uniformdoses to the region treated by brachytherapy. The dose conformality and normal tissue avoidance needed to make the high total tumor dose tolerable is generally provided by the brachytherapy component of treatment. Usually, the brachytherapy and external beam components of treatment are planned independently of one another.

Original languageEnglish
Title of host publicationImage-Guided IMRT
PublisherSpringer Berlin Heidelberg
Pages423-437
Number of pages15
ISBN (Print)354020511X, 9783540205111
DOIs
StatePublished - 2006

Fingerprint

Dive into the research topics of 'Integration of IMRT and brachytherapy'. Together they form a unique fingerprint.

Cite this